Anticancer Nanotherapeutics for Lung Cancer Therapy
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".
Deadline for manuscript submissions: 31 July 2026 | Viewed by 1207
Special Issue Editors
Interests: inhalable nanomedicines; drug delivery; ferroptosis; biological fate
Special Issues, Collections and Topics in MDPI journals
Interests: cocrystal; crystal engineering; ionic liquid drug delivery systems
Interests: antitumor nanomedicine; ROS-mediated tumor oxidation therapy; ROS-responsive prodrug/nanodrug delivery; ROS-mediated immunotherapy; ROS-mediated combination therapy; advanced targeted drug delivery system with nanomedicine or macrophage; ROS-responsive hydrogel
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Lung cancer has become one of the major types of cancers threatening the health and life of humankind, with continuously growing mortality and morbidity. The pharmaceutical sector has made many efforts to combat lung cancer, and a series of novel therapeutics have been developed. Among nanotherapeutics, those that shed light on their superior drug loading and delivery attributes are particularly noteworthy. Nanotherapeutics refer to nanosystems in which therapeutic agents are encapsulated or attached to nanoparticles, such as liposomes, polymeric micelles, and nanogels. Most importantly, they are asserted to possess enhanced targeting functions over conventional therapeutics, due to the passive or active targeting abilities. The relevant topics are hotspots in the current scientific community, which attract research interests from all over the world.
This Special Issue aims to welcome impressive contributions (articles, reviews, communications, etc.) on anticancer nanotherapeutics for lung cancer therapy. The Guest Editor team believes that input from global scientists can contribute to the understanding of nanotherapeutics design and development, and accelerate the advancement of lung cancer treatment. Nanomedicines intended for pulmonary delivery will be especially encouraged because of the pathological nature of lung cancer, while targeting nanosystems delivered by other routes are also considered. We look forward to your contributions.
Dr. Zhengwei Huang
Dr. Xialin Dai
Dr. Yanjuan Huang
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- lung cancer
- nanotherapeutics
- nanoparticles
- liposomes
- polymeric micelles
- nanogels
- targeting nanosystems
- pulmonary delivery
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
